OUR PRODUCTS

MOBILE APPS

GENERAL INFO

FOLD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Amicus Therapeutics (FOLD) Earnings Date & Reports

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

FOLD is expected to report earnings to rise 134.00% to 2 cents per share on November 05

Amicus Therapeutics FOLD Stock Earnings Reports

Q3'25

Est.

$0.02

Q2'25

Beat

by $0.12

Q1'25

Beat

by $0.05

Q4'24

Beat

by $0.08

Q3'24

Beat

by $0.10

The last earnings report on July 31 showed earnings per share of 0 cents, beating the estimate of -10 cents. With 123.17K shares outstanding, the current market capitalization sits at 2.08B.

View a ticker or compare two or three

Compare

Earnings Traders Earnings Traders

Annualized Return+23%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

FOLD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For FOLD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FOLD showed earnings on July 31, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

47 Hulfish Street

Phone

+1 609 662-2000

Employees

517

Web

https://www.amicusrx.com